Works by Guy, Bruno
Results: 24
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.
- Published in:
- PLoS ONE, 2019, p. 1, doi. 10.1371/journal.pone.0216533
- By:
- Publication type:
- Article
Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).
- Published in:
- Transactions of the Royal Society of Tropical Medicine & Hygiene, 2018, v. 112, n. 4, p. 158, doi. 10.1093/trstmh/try037
- By:
- Publication type:
- Article
Cross-Serotype Immunity Induced by Immunization with a Conserved Rhinovirus Capsid Protein.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 9, p. 1, doi. 10.1371/journal.ppat.1003669
- By:
- Publication type:
- Article
From 'perfect mix' to 'potion magique' — regulatory T cells and anti-inflammatory cytokines as adjuvant targets: reply from Guy.
- Published in:
- 2008
- By:
- Publication type:
- Letter
The perfect mix: recent progress in adjuvant research.
- Published in:
- Nature Reviews Microbiology, 2007, v. 5, n. 7, p. 505, doi. 10.1038/nrmicro1681
- By:
- Publication type:
- Article
Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 4, p. 1, doi. 10.1093/ofid/ofv172
- By:
- Publication type:
- Article
Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Different Innate Signatures Induced in Human Monocyte-derived Dendritic Cells by Wild-Type Dengue 3 Virus, Attenuated but Reactogenic Dengue 3 Vaccine Virus, or Attenuated Nonreactogenic Dengue 1–4 Vaccine Virus Strains.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 1, p. 103, doi. 10.1093/infdis/jiq022
- By:
- Publication type:
- Article
Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strains.
- Published in:
- 2011
- By:
- Publication type:
- journal article
When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 174, doi. 10.3390/vaccines8020174
- By:
- Publication type:
- Article
Immunological Foundations to the Quest for New Vaccine Adjuvants.
- Published in:
- BioDrugs, 2004, v. 18, n. 2, p. 79, doi. 10.2165/00063030-200418020-00002
- By:
- Publication type:
- Article
Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination.
- Published in:
- Human Vaccines & Immunotherapeutics, 2017, v. 13, n. 9, p. 2004, doi. 10.1080/21645515.2017.1333211
- By:
- Publication type:
- Article
Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico.
- Published in:
- Human Vaccines & Immunotherapeutics, 2014, v. 10, n. 10, p. 2853, doi. 10.4161/21645515.2014.972131
- By:
- Publication type:
- Article
Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore.
- Published in:
- Human Vaccines & Immunotherapeutics, 2013, v. 9, n. 11, p. 2317, doi. 10.4161/hv.25562
- By:
- Publication type:
- Article
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation.
- Published in:
- Nature Medicine, 2008, v. 14, n. 2, p. 199, doi. 10.1038/nm1713
- By:
- Publication type:
- Article
Substitution of Wild-Type Yellow Fever Asibi Sequences for 17D Vaccine Sequences in ChimeriVax-Dengue 4 Does Not Enhance Infection of Aedes aegypti Mosquitoes.
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 5, p. 686, doi. 10.1086/527328
- By:
- Publication type:
- Article
Recombinant Chimeric Virus with Wild-Type Dengue 4 Virus Premembrane and Envelope and Virulent Yellow Fever Virus Asibi Backbone Sequences Is Dramatically Attenuated in Nonhuman Primates.
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 5, p. 693, doi. 10.1086/527329
- By:
- Publication type:
- Article
An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B.
- Published in:
- European Journal of Immunology, 1989, v. 19, n. 12, p. 2383, doi. 10.1002/eji.1830191231
- By:
- Publication type:
- Article
Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
- Published in:
- European Journal of Immunology, 1989, v. 19, n. 9, p. 1537, doi. 10.1002/eji.1830190904
- By:
- Publication type:
- Article
HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus.
- Published in:
- European Journal of Immunology, 1988, v. 18, n. 12, p. 1917, doi. 10.1002/eji.1830181208
- By:
- Publication type:
- Article
Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials.
- Published in:
- PLoS Neglected Tropical Diseases, 2016, v. 10, n. 7, p. 1, doi. 10.1371/journal.pntd.0004830
- By:
- Publication type:
- Article
Drug Patents: A Historical Look at a Controversial Subject.
- Published in:
- Erciyes Medical Journal / Erciyes Tip Dergisi, 2022, v. 44, n. 1, p. 1, doi. 10.14744/etd.2021.78370
- By:
- Publication type:
- Article
Stability of Yellow Fever Virus under Recombinatory Pressure as Compared with Chikungunya Virus.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023247
- By:
- Publication type:
- Article